Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19

Thumbnail

View/Open

Date

2021

Author

Özdemir, İbrahim Halil
Özlek, Bülent
Özen, Mehmet Burak
Gündüz, Ramazan
Çetin, Nurullah
Bilge, Ali Rıza

Metadata

Show full item record

Citation

Özdemir, İ. H., Özlek, B., Özen, M. B., Gündüz, R., Çetin, N., & Bilge, A. R. (2021). Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19. International Journal of Clinical Practice, 75(2) doi:10.1111/ijcp.13896

Abstract

Hydroxychloroquine (HCQ) and azithromycin (AZM) are widely used in off‐label treatment of novel coronavirus disease (COVID‐19). However, cardiac safety of these drugs is still controversial in COVID‐19. Therefore, we aimed to evaluate association of HCQ or HCQ + AZM treatment regimens, corrected QT (QTc) interval and malignant ventricular arrhythmias in hospitalized patients.

Source

International Journal of Clinical Practice

Volume

75

Issue

2

URI

https://doi.org/10.1111/ijcp.13896
https://www.scopus.com/record/display.uri?eid=2-s2.0-85100128961&origin=SingleRecordEmailAlert&dgcid=raven_sc_search_en_us_email&txGid=e1810b624fbcf3e14e54743243158d13
https://hdl.handle.net/20.500.12809/8943

Collections